Join
Live feed
·
INSIDERFilingvia Quantisnow
Monopar Therapeutics Inc. logo

Chief Financial Officer Vu Quan Anh converted options into 1,228 shares and covered exercise/tax liability with 507 shares, increasing direct ownership by 48% to 2,221 units (SEC Form 4) (for withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MNPR (Monopar Therapeutics Inc.) and more on Quantisnow.